Suppr超能文献

腹膜肿瘤指数(PCI)对预测晚期卵巢癌新辅助化疗后手术结局的重要性。

The importance of the Peritoneal Cancer Index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer.

机构信息

Department Gynecology and Obstetrics, Florence-Nightingale-Krankenhaus, Kreuzbergstr. 79, 40489, Duesseldorf, Germany.

Department Gynecology and Obstetrics, Universitätsklinikum Köln, Cologne, Germany.

出版信息

Arch Gynecol Obstet. 2022 Nov;306(5):1665-1672. doi: 10.1007/s00404-022-06527-y. Epub 2022 Mar 31.

Abstract

PURPOSE

Achieving complete cytoreduction (CCR) is crucial for a patient's prognosis with advanced epithelial ovarian cancer (EOC). So far, prognostic predictors have failed to predict surgical outcome after neoadjuvant chemotherapy (NACT). In clinical trials, scores were used to predict operability in recurrent ovarian cancer (Harter et al. in N Engl J Med 385(23):2123-2131, 2021) but there is no known prediction score for CCR after NACT. The Peritoneal Cancer Index (PCI) is an established tool to predict surgical outcome in primary setting (Lampe et al. in 25:135-144, 2015). We now examined the predictive power of the PCI to achieve CCR after NACT.

METHODS

In this single-center study, the data of patients with advanced stage EOC (FIGO > IIIb) treated between 01/2015 and 12/2020 were analyzed retrospectively. Inclusion criteria were a mandatory staging laparoscopy, a PCI score > 25, and NACT. CT scans were analyzed in blinded fashion according to RECIST criteria (Borgani et al. in 237; 93-99, 2019) Reaction of PCI after NACT was compared with the analysis of radiologic imaging and CA-125 levels.

RESULTS

Three hundred and sixteen patients were screened, 62 were treated with NACT, and 23 were included in our analysis. 87% of cases presented with an FIGO IIIc stadium. The reduction of PCI itself after NACT showed to be the most powerful predictor for achieving CCR. The reduction of the initial PCI score by minimum of 8.5 points was a better predictor for CCR than reaching a PCI < 25. In contrast to data deriving from patients undergoing primary debulking surgery (PDS), we found a PCI of 17, rather than 25, to be a more valuable cut-off for CCR in neoadjuvant-treated patients.

CONCLUSION

The extend of PCI reduction after NACT is a better predictor for achieving CCR compared with CA125 levels and radiologic imaging. The PCI must be assessed differently in neoadjuvant setting than in a primary situation. CCR was most likely for a post-NACT PCI < 17.

摘要

目的

对于晚期上皮性卵巢癌(EOC)患者,实现完全肿瘤细胞减灭术(CCR)是预后的关键。迄今为止,预测指标未能预测新辅助化疗(NACT)后的手术结果。在临床试验中,评分用于预测复发性卵巢癌的可操作性(Harter 等人,《新英格兰医学杂志》385(23):2123-2131,2021),但目前尚不知道 NACT 后 CCR 的预测评分。腹膜肿瘤指数(PCI)是一种用于预测原发性疾病手术结果的成熟工具(Lampe 等人,《25》:135-144,2015)。我们现在检查了 PCI 在 NACT 后实现 CCR 的预测能力。

方法

本单中心研究回顾性分析了 2015 年 1 月至 2020 年 12 月期间接受治疗的晚期 EOC(FIGO>IIIb)患者的数据。纳入标准为强制性分期腹腔镜检查、PCI 评分>25 分和 NACT。根据 RECIST 标准(Borgani 等人,《237》:93-99,2019)对 CT 扫描进行盲法分析。比较 NACT 后 PCI 反应与影像学分析和 CA-125 水平。

结果

筛选了 316 名患者,其中 62 名接受了 NACT,23 名纳入本分析。87%的病例为 FIGO IIIc 期。NACT 后 PCI 本身的降低是实现 CCR 的最有力预测指标。与达到 PCI<25 相比,PCI 初始评分至少降低 8.5 分是 CCR 的更好预测指标。与接受原发性肿瘤减灭术(PDS)的患者数据相比,我们发现 PCI 为 17 而不是 25 是 NACT 治疗患者 CCR 的更有价值的截止值。

结论

与 CA125 水平和影像学相比,NACT 后 PCI 降低程度是预测 CCR 的更好指标。在新辅助治疗环境中,PCI 的评估必须与原发性疾病不同。NACT 后 PCI<17 最有可能实现 CCR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d755/9519707/049c7632fdfc/404_2022_6527_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验